Properties
Description
CFMTI inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets human mGluR1a, and rat mGluR1a.
Molecular Formula
C19H16FN5O
Targets
Human mGluR1a: 2.6 nM; Rat mGluR1a: 2.3 nM
Applications
CFMTI can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.